Publikationen
2025
30 Publikationen
1. Schleifenbaum JK, Morgenthaler J, Sharma SJ, Klußmann JP, Linde P, Wegen S, Rosenbrock J, Baues C, Fokas E, Khor R, Ng SP, Marnitz S, Trommer M Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes-a single centre analysis. Radiat Oncol 20(1). 2025.
DOI: https://doi.org/10.1186/s13014-024-02570-y
2. Dapper H, Rudroff C, Linde P, Rosenbrock J, Schmitz J, Ferdinandus S, Jablonska K, Martin D, Rödel C, Fokas E Radiation therapy in anal high-grade squamous intraepithelial lesions-a pattern of care analysis in German-speaking countries. Strahlenther Onkol 201(7):699-705. 2025.
DOI: https://doi.org/10.1007/s00066-025-02380-5
3. Dapper H, Fleischmann M, Tselis N, Diefenhardt M, Hofheinz RD, Weiß C, Grabenbauer GG, Merten R, Grosu AL, Kirste S, Rieken S, Claßen J, Langer C, Kuhnt T, Schmidberger H, Ghadimi M, Giordano F, Nestle U, Koerber SA, Bock F, Geiger M, Polat B, Bruns CJ, Dieplinger G, Popp F, Zander T, Brunner T, Tribius S, Arnold D, Wurschi G, Piso P, Friede T, Hörner-Rieber J, Gkika E, Rödel C, Fokas E, German Rectal Cancer Study Group ACO/ARO/AIO-22 - External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group. Clin Transl Radiat Oncol 53. 2025.
DOI: https://doi.org/10.1016/j.ctro.2025.100958
4. Gani C, Fokas E, Polat B, Ott OJ, Diefenhardt M, Königsrainer A, Böke S, Kirschniak A, Bachmann R, Wichmann D, Bitzer M, Clasen S, Grosse U, Hoffmann R, Götz M, Hofheinz RD, Germer E, Germer CT, Fietkau R, Martus P, Zips D, Rödel C Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial. Lancet Gastroenterol Hepatol 10(6):562-572. 2025.
DOI: https://doi.org/10.1016/S2468-1253(25)00049-4
5. Rödel F, Fleischmann M, Diefenhardt M, Dapper H, Hoffmann A, Rödel C, Martin D, Fokas E Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer. Nat Rev Clin Oncol 22(7):483-498. 2025.
DOI: https://doi.org/10.1038/s41571-025-01025-x
6. Dapper H, Oertelt-Prigione S, Stadler G, Weishaupt N, Quaas A, Romotzky V, Haarmann L, Fokas E, Fan J, Linde P, Zander T, Görner M, Wortmann L Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in Germany. Transl Oncol 60. 2025.
DOI: https://doi.org/10.1016/j.tranon.2025.102493
7. Fokas E, Rödel C Endorectal brachytherapy for organ preservation in patients with rectal cancer: A paradigm shift? Eur J Surg Oncol 51(7). 2025.
DOI: https://doi.org/10.1016/j.ejso.2025.110018
8. Hofheinz RD, Fokas E, Benhaim L, Price TJ, Arnold D, Beets-Tan R, Guren MG, Hospers GAP, Lonardi S, Nagtegaal ID, Perez RO, Cervantes A, Martinelli E, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 36(9):1007-1024. 2025.
DOI: https://doi.org/10.1016/j.annonc.2025.05.528
9. Kosmala R, Hammann AS, Paulus P, Zimmermann M, Wittig-Sauerwein A, Germer CT, Ghadimi M, Hofheinz RD, Diefenhardt M, Fokas E, Rödel C, Polat B, German Rectal Cancer Study Group Quality of Life After Two Sequences of Total Neoadjuvant Treatment in Patients With Locally Advanced Rectal Cancer in the Randomized CAO/ARO/AIO-12 Phase 2 Trial. Int J Radiat Oncol Biol Phys 123(3):806-816. 2025.
DOI: https://doi.org/10.1016/j.ijrobp.2025.05.018
10. Williams H, Fokas E, Diefenhardt M, Lee C, Verheij FS, Omer DM, Lin ST, Dunne RF, Marcet J, Cataldo P, Polite B, Piso P, Polat B, Dapper H, Ghadimi M, Hofheinz RD, Qin LX, Saltz LB, Wu AJ, Gollub MJ, Smith JJ, Weiser MR, Rödel C, Garcia-Aguilar J, German Rectal Cancer Study Group , OPRA Consortium Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials. Ann Oncol 36(5):543-547. 2025.
DOI: https://doi.org/10.1016/j.annonc.2025.01.006
11. Gaedcke J, Sahrhage M, Ebeling M, Azizian A, Rühlmann F, Bernhardt M, Grade M, Bechstein WO, Germer CT, Grützmann R, Piso P, Hofheinz RD, Staib L, Beißbarth T, Kosmala R, Fokas E, Rödel C, Ghadimi M, German Rectal Cancer Study Group Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial. Sci Rep 15(1). 2025.
DOI: https://doi.org/10.1038/s41598-024-83105-z
12. Diefenhardt M, Kosmala R, Fleischmann M, Martin D, Hofheinz RD, Ghadimi M, Rödel C, Polat B, Fokas E Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer: 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison. ESMO Open 10(3). 2025.
DOI: https://doi.org/10.1016/j.esmoop.2025.104483
13. Völler L, Fokas E, Rödel C, Martin D [Less is more: dose de-escalation in early anal cancer-Clinical and functional aspects of quality of life from the PLATO-ACT4 trial]. Strahlenther Onkol 201(9):976-978. 2025.
DOI: https://doi.org/10.1007/s00066-025-02430-y
14. Goetze O, Kloft M, Fokas E, Schmidt T, Dapper H Treatment of oligometastatic gastrointestinal tumors: Options for surgical, radiation, and systemic therapy Onkologie (Heidelberg, Germany) 31(7):688-700. 2025.
DOI: https://doi.org/10.1007/s00761-025-01737-w
15. Linde P, Hallal H, Charkina P, Adams A, Frank J, Wegen S, Fan J, Nadjiri L, Zims H, Stosch C, Baues C Diversity competence in medical education: short-term effectiveness of an interprofessional diversity-specific undergraduate learning. BMC Med Educ 25(1). 2025.
DOI: https://doi.org/10.1186/s12909-025-06824-5
16. Linde P, Leibnitz M, Weinzierl S, Taubert LS, Albers S Bringing Sexuality into the Conversation: Evaluating Medical Students' Perceptions of a Competency-Based Sexual History-Taking Seminar Int J Sex Health. 2025.
DOI: https://doi.org/10.1080/19317611.2025.2571882
17. Galietta E, Donati CM, Bazzocchi A, Sassi R, Zamfir AA, Hovenier R, Bos C, Hendriks N, Boomsma MF, Huhtala M, Blanco Sequeiros R, Grüll H, Ferdinandus S, Verkooijen HM, Morganti AG Impact of Pain Education on Pain Relief in Oncological Patients: A Narrative Review of Systematic Reviews and Meta-Analyses. Cancers (Basel) 17(10). 2025.
DOI: https://doi.org/10.3390/cancers17101683
18. Wurschi G, Kesselmeier M, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, Schunn F, von Gruben ME, Büttner M, Hoffmann E, Rühle A, Beier J, Ferdinandus S, Trommer M, Sahin EC, Hlouschek J, Aninditha K, von Ohlen DS, Kaufmann J, Depardon A, Ha HM, Trommer S, Kessler C, Cieslak A, Fabian A, Rißner F, Römer M, Mäurer M, Pietschmann K Short-course radiotherapy versus long-course chemoradiotherapy in total neoadjuvant therapy of rectal cancer - A multicenter analysis of early outcomes and toxicity. Radiother Oncol 213. 2025.
DOI: https://doi.org/10.1016/j.radonc.2025.111194
19. Ferdinandus S, Rühle A, Lamrani A, Frei C, Kaufmann J, Mäurer M, Wurschi G, Jiang P, Ehret F, Baehr A, Hardt A, Bodensohn R, Käsmann L, Waltenberger M, Scafa D, Layer JP, Troost EGC, Elkhamisy SA, Jazmati D, Franklin C, Neppl S, Hagemeier A, Trommer M Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study. J Immunother Cancer 13(10). 2025.
DOI: https://doi.org/10.1136/jitc-2025-012717
20. Chen J, Levy A, Tian AL, Huang X, Cai G, Fidelle M, Rauber C, Ly P, Pizzato E, Sitterle L, Piccinno G, Liu P, Durand S, Mao M, Zhao L, Iebba V, Felchle H, Mallard de La Varende AL, Fischer JC, Thomas S, Greten TF, Jones JC, Monge C, Demaria S, Formenti S, Belluomini L, Dionisi V, Massard C, Blanchard P, Robert C, Quevrin C, Lopes E, Clémenson C, Mondini M, Meziani L, Zhan Y, Zeng C, Cai Q, Morel D, Sun R, Laurent PA, Mangoni M, Di Cataldo V, Arilli C, Trommer M, Wegen S, Neppl S, Riechelmann RP, Camandaroba MP, Neto ES, Fournier PE, Segata N, Holicek P, Galluzzi L, Buqué A, Alves Costa Silva C, Derosa L, Kroemer G, Chen C, Zitvogel L, Deutsch E Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients. Cancer Cell 43(3):361-379.e10. 2025.
DOI: https://doi.org/10.1016/j.ccell.2025.02.010
21. Nägler F, Vorbach S, Mohamed AA, Thaqi S, Adebahr S, Ehret F, Kraft J, Fabian A, Weissmann T, Kaufmann J, Drabke S, Looman EL, Waltenberger M, Kraus KM, Grohmann M, Dehl K, Rogers S, Gawish A, Becker JN, Klement RJ, Partl R, Trommer M, Grosu AL, Rimner A, Gkika E, Riesterer O, Putz F, Ganswindt U, Moustakis C, Nicolay NH, Brunner TB, Blanck O, Wittig-Sauerwein A, Balermpas P, Rühle A Pulmonary Stereotactic Body Radiation Therapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma: A Multicenter Retrospective Study. Int J Radiat Oncol Biol Phys 122(1):140-149. 2025.
DOI: https://doi.org/10.1016/j.ijrobp.2024.12.015
22. Trommer S, Müller JA, Oertel M, Ehret F, Roohani S, Ha HM, Ha QN, Hering K, Nägler F, Lange T, Mäurer M, Weissmann T, Putz F, Trommer M, Baues C, Dobiasch S, Waltenberger M, Skripcak T, Vordermark D, Medenwald D Tumor volume change at radiation boost planning to estimate the response to chemoradiotherapy in stage III unresectable NSCLC (TORCH): a multicenter retrospective observational study. Strahlenther Onkol 201(10):1001-1013. 2025.
DOI: https://doi.org/10.1007/s00066-025-02374-3
23. Muhler P, Akuamoa-Boateng D, Rosenbrock J, Stock S, Müller D, Heidenreich A, Simões Corrêa Galendi J Cost-utility analysis of MR imaging-guided transurethral ultrasound ablation for the treatment of low- to intermediate-risk localised prostate cancer. BMJ Open 15(1). 2025.
DOI: https://doi.org/10.1136/bmjopen-2024-088495
24. Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, Schaub V, Hüttmann A, Keil F, Dierlamm J, Hänel M, Novak U, Meissner J, Hellmuth JC, Mathas S, Zijlstra JM, Fosså A, Viardot A, Hertenstein B, Martin S, Giri P, Kamper P, Molin D, Jablonski J, Damaschin C, Robertz AS, Rosenbrock J, Fuchs M, Borchmann P, Behringer K Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial. Lancet Oncol 26(8):1081-1090. 2025.
DOI: https://doi.org/10.1016/S1470-2045(25)00262-1
25. Valentini C, Perwein T, Bison B, Gielen GH, Knerlich-Lukoschus F, Bock HC, Seidel C, Kortmann RD, Sturm D, Benesch M, Nussbaumer G, Krischer JM, von Bueren AO, Eyrich M, Friker LL, Hoffmann M, Gkika E, Wittig-Sauerwein A, Hörner-Rieber J, Schwarz R, Jablonska K, Hoffmann W, Vordermark D, Rieken S, Höng L, Rödel C, Timmermann B, Fennell JT, Claviez A, Karremann M, Kramm CM, Krause M Haematotoxicity of Craniospinal Radiochemotherapy for Metastatic Paediatric High-Grade Glioma. Clin Oncol (R Coll Radiol) 48. 2025.
DOI: https://doi.org/10.1016/j.clon.2025.103956
26. Rueß D, Vojacek S, Güngör E, Lüers JC, Hunsche S, Jablonska K, Kocher M, Ruge MI Longitudinal Evaluation of Vestibular Symptoms in Patients with Vestibular Schwannoma After Robotic-Guided Stereotactic Radiosurgery Using the Dizziness Handicap Inventory (DHI). J Clin Med 14(2). 2025.
DOI: https://doi.org/10.3390/jcm14020299
27. Thummerer A, van der Bijl E, Galapon AJ, Kamp F, Savenije M, Muijs C, Aluwini S, Steenbakkers RJHM, Beuel S, Intven MP, Langendijk JA, Both S, Corradini S, Rogowski V, Terpstra M, Wahl N, Kurz C, Landry G, Maspero M SynthRAD2025 Grand Challenge dataset: Generating synthetic CTs for radiotherapy from head to abdomen. Med Phys 52(7). 2025.
DOI: https://doi.org/10.1002/mp.17981
28. Sonntag N, Eichner M, Judge M, Kocher M, Ruess D, Ruge MI, Hunsche S Comparative evaluation of normal tissue objective functions in robotic radiosurgery planning for solitary brain tumors. J Appl Clin Med Phys 26(11). 2025.
DOI: https://doi.org/10.1002/acm2.70318
29. Thomann B, Fechter T, Fischer J, Runz A, Roers J, Ludwig U, Grehn M, Grohmann M, Ziemann C, Judge M, Baus W, Grahle M, Walke M, Bathen B, Köhn J, Käthner P, Shariff M, Matthis R, Fleckenstein J, Großmann S, Streller T, Howitz S, Priegnitz M, Weigel R, Winkler P, Blanck O, Schmitt D, Beck J, Machein M, Pappas E, Popp I, Reiner M, Karger CP, Moustakis C, Bock M, Grosu AL, Baltas D Multicenter multiplatform pattern-of-practice analysis of single-isocenter multitarget stereotactic radiosurgery. Strahlenther Onkol 201(9):953-962. 2025.
DOI: https://doi.org/10.1007/s00066-025-02424-w
30. Shariff M, Tillner F, Schramm O, Karle H, Delaperriere M, Großmann S, Neppl S, Moustakis C, Lips F, Auerbach H, Knobe S, Garbe S, Janning M, Köhn J, Küchler S, Gemes M, Kühl S, Mündlein L, Ubrich F, Dittrich E, Krayenbuehl J, Walke M, Medenwald D, Schmidt M, Maurer N, Hustedt A, Frey B, Bert C, Riethmüller P Multicenter comparison of different total body irradiation techniques - Results from the DGMP Working group large-field irradiation techniques. Z Med Phys. 2025.
DOI: https://doi.org/10.1016/j.zemedi.2025.11.003
2024
41 Publikationen
1. Büttner M, Melton P, Fietkau R, Petersen C, Krause M, Borgmann K, Wolf U, Niyazi M, Christiansen H, Höller U, Schmitt D, Käsmann L, Linde P, Fleischmann DF, Ziegler S, Bresch A, Mäurer M Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO). Strahlenther Onkol 200(2):151-158. 2024.
DOI: https://doi.org/10.1007/s00066-023-02162-x
2. Fabian A, Rühle A, Domschikowski J, Trommer M, Wegen S, Becker JN, Wurschi G, Boeke S, Sonnhoff M, Fink CA, Käsmann L, Schneider M, Bockelmann E, Treppner M, Mehnert-Theuerkauf A, Nicolay NH, Krug D, Young DEGRO Group Satisfaction with radiotherapy care among cancer patients treated in Germany-secondary analysis of a large multicenter study. Strahlenther Onkol 200(6):487-496. 2024.
DOI: https://doi.org/10.1007/s00066-023-02176-5
3. Ujkic L, Sutanto R, Knöll P, Zarghooni K, Rosenbrock J, Walter S [Acute spinal cord compression under systemic therapy - radiotherapy or surgery?]. Aktuelle Urol 55(1):50-53. 2024.
DOI: https://doi.org/10.1055/a-2099-1847
4. Wegen S, Weindler J, Voltin CA, van Heek L, Schomäcker K, Fischer T, Marnitz S, Kobe C, Drzezga A, Roth KS Dual-tracer PET/CT protocol with [18F]FDG and [68Ga]Ga-FAPI-46 outperforms single-tracer PET/CT with [18F]FDG in different cancer types, resulting in larger functional and gross tumor volume. Strahlenther Onkol 200(1):28-38. 2024.
DOI: https://doi.org/10.1007/s00066-023-02117-2
5. Wegen S, Claus K, Linde P, Rosenbrock J, Trommer M, Zander T, Tuchscherer A, Bruns C, Schlößer HA, Schröder W, Eich ML, Fischer T, Schomäcker K, Drzezga A, Kobe C, Roth KS, Weindler JJ Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer. Radiat Oncol 19(1). 2024.
DOI: https://doi.org/10.1186/s13014-024-02430-9
6. Wegen S, Nestle U, Zamboglou C, Spohn SKB, Nicolay NH, Unterrainer LM, Koerber SA, La Fougère C, Fokas E, Kobe C, Eze C, Grosu AL, Fendler WP, Holzgreve A, Werner R, Schmidt-Hegemann NS Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology. Strahlenther Onkol 200(11):931-941. 2024.
DOI: https://doi.org/10.1007/s00066-024-02260-4
7. Morgenthaler J, Rühle A, Kirste S, Trommer M [SBRT for primary kidney cancer: Data from the multicentre prospective FASTRACK II study]. Strahlenther Onkol 200(8):733-735. 2024.
DOI: https://doi.org/10.1007/s00066-024-02238-2
8. Wurschi GW, Rühle A, Domschikowski J, Trommer M, Ferdinandus S, Becker JN, Boeke S, Sonnhoff M, Fink CA, Käsmann L, Schneider M, Bockelmann E, Krug D, Nicolay NH, Fabian A, Pietschmann K Patient-Relevant Costs for Organ Preservation versus Radical Resection in Locally Advanced Rectal Cancer. Cancers (Basel) 16(7). 2024.
DOI: https://doi.org/10.3390/cancers16071281
9. Morgenthaler J, Trommer M, Khor R, Wada M, Bahig H, Garden AS, Thai A, Gan H, Fokas E, Ping Ng S Can we safely de-escalate HPV+ oropharyngeal cancers? - A review of current practices and novel approaches. Oral Oncol 159. 2024.
DOI: https://doi.org/10.1016/j.oraloncology.2024.107089
10. Trommer M, Ruehle A, Lamrani A, Schmitter C, Kaufmann J, Maeurer M, Wurschi G, Jiang P, Ehret F, Baehr A, Hardt A, Bodensohn R, Kaesmann L, Jazmati D, Neppl S, Hagemeier A, Wegen S ARTIC - Abscopal effects in metastasized cancer patients treated with radiotherapy and immune checkpoint inhibition Preliminary results of a large observational multicenter study of the young DEGRO Oncology Research and Treatment 47 Suppl 1:144-145. 2024.
DOI: nicht verfügbar
11. Rosenbrock J, Kaul H, Oertel M, Celik E, Linde P, Fan J, Eichenauer DA, Bröckelmann PJ, von Tresckow B, Kobe C, Dietlein M, Fuchs M, Borchmann P, Eich HT, Baues C Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys 120(5):1344-1352. 2024.
DOI: https://doi.org/10.1016/j.ijrobp.2024.04.015
12. Kagawa Y, Smith JJ, Fokas E, Watanabe J, Cercek A, Greten FR, Bando H, Shi Q, Garcia-Aguilar J, Romesser PB, Horvat N, Sanoff H, Hall W, Kato T, Rödel C, Dasari A, Yoshino T Future direction of total neoadjuvant therapy for locally advanced rectal cancer. Nat Rev Gastroenterol Hepatol 21(6):444-455. 2024.
DOI: https://doi.org/10.1038/s41575-024-00900-9
13. Wang H, Gong L, Huang X, White SD, Chung HT, Vesprini D, Petchiny TN, Fokas E, He H, Kerbel RS, Liu SK Potentiating Salvage Radiotherapy in Radiorecurrent Prostate Cancer Through Anti-CTLA4 Therapy: Implications from a Syngeneic Model. Cancers (Basel) 16(16). 2024.
DOI: https://doi.org/10.3390/cancers16162839
14. Diefenhardt M, Martin D, Fleischmann M, Hofheinz RD, Ghadimi M, Rödel C, Fokas E Tumor Response and Its Impact on Treatment Failure in Rectal Cancer: Does Intensity of Neoadjuvant Treatment Matter? Cancers (Basel) 16(21). 2024.
DOI: https://doi.org/10.3390/cancers16213673
15. Maier SH, Schönecker S, Anagnostatou V, Garny S, Nitschmann A, Fleischmann DF, Büttner M, Kaul D, Imhoff D, Fokas E, Seidel C, Hau P, Kölbl O, Popp I, Grosu AL, Haussmann J, Budach W, Celik E, Kahl KH, Hoffmann E, Tabatabai G, Paulsen F, Holzgreve A, Albert NL, Mansmann U, Corradini S, Belka C, Niyazi M, Bodensohn R Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06). Clin Transl Radiat Oncol 47. 2024.
DOI: https://doi.org/10.1016/j.ctro.2024.100790
16. Rehn S, Oertel M, Linde P, Mäurer M, Elsayad K, Pepper NB, Rolf D, Kahn JM, Plastaras JP, Gunther JR, Eich HT Knowledge and competences in hematological malignancies amongst radiation oncology residents in Germany-results from a national survey. Strahlenther Onkol 200(11):925-930. 2024.
DOI: https://doi.org/10.1007/s00066-024-02236-4
17. Fokas E, Williams H, Diefenhardt M, Lin S, Qin LX, Piso P, Dapper H, Germer CT, Grützmann R, Tim Friede J, Joshua Smith J, Saltz LB, Wu AJ, Weiser MR, Omer D, Ghadimi M, Hofheinz RD, Garcia-Aguilar J, Rödel C, German Rectal Cancer Study Group and the OPRA Consortium Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials. Eur J Cancer 210. 2024.
DOI: https://doi.org/10.1016/j.ejca.2024.114291
18. Martin D, Rödel F, Hehlgans S, Looso M, Ziegler PK, Fleischmann M, Diefenhardt M, Fries L, Kalinauskaite G, Tinhofer I, Zips D, Gani C, Rödel C, Fokas E Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma. npj Precis Oncol 8(1). 2024.
DOI: https://doi.org/10.1038/s41698-024-00585-y
19. Weissmann T, Deloch L, Grohmann M, Trommer M, Fabian A, Ehret F, Stefanowicz S, Rühle A, Lettmaier S, Putz F, Shariff M, Wegen S, Matschke J, Sperk E, Schröder A German radiation oncology's next generation: a web-based survey of young biologists, medical physicists, and physicians-from problems to solutions. Strahlenther Onkol 200(12):1005-1024. 2024.
DOI: https://doi.org/10.1007/s00066-024-02305-8
20. Fokas E, Smith JJ, Garcia-Aguilar J, Glynne-Jones R, Buyse M, Rödel C Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited. J Clin Oncol 42(8):872-875. 2024.
DOI: https://doi.org/10.1200/JCO.23.01196
21. Trommer M, Ruehle A, Lamrani A, Schmitter C, Kaufmann J, Maeurer M, Wurschi G, Jiang P, Ehret F, Baehr A, Hardt A, Bodensohn R, Kaesmann L, Jazmati D, Waltenberger M, Neppl S, Hagemeier A, Layer JP, Scafa D, Wegen S Irradiating patients with progression during ICI triggers abscopal responses and enhances survival Radiother Oncol 194 Suppl 1:S1850-S1854. 2024.
DOI: nicht verfügbar
22. Wegen S, Claus K, Linde P, Rosenbrock J, Trommer M, Zander T, Tuchscherer A, Bruns C, Schloesser H, Schroeder W, Eich ML, Fischer T, Schomacker K, Drzezga A, Kobe C, Roth KS, Weindler JJ Impact of FAPI PET/CT on radiotherapeutic management of esophageal cancer Radiother Oncol 194 Suppl 1:S2284-S2286. 2024.
DOI: nicht verfügbar
23. Wegen S, Ruehle A, Lamrani A, Schmitter C, Kaufmann J, Maeurer M, Wurschi G, Jiang P, Ehret F, Baehr A, Hardt A, Bodensohn R, Kaesmann L, Waltenberger M, Layer JP, Scafa D, Jazmati D, Neppl S, Hagemeier A, Trommer M Abscopal effects in patients with radiotherapy and checkpoint inhibition: a study of the young DEGRO Radiother Oncol 194 Suppl 1:S1899-S1902. 2024.
DOI: nicht verfügbar
24. Fan J, Kutsch N, Heger JM, Sieg N, Godel P, Gruell H, Heger E, Rosenbrock J, Celik E, Linde P, Fokas E, Borchmann P, von Tresckow B, Baues C Does CAR T-Cell Level during Post-CART DLBCL Progression Influence the Response to Salvage Radiotherapy and Patient Outcomes? Int J Radiat Oncol Biol Phys 120 Suppl S(2):S67-S67. 2024.
DOI: nicht verfügbar
25. Brunner TB, Lordick F, Schmoor C, Schmidberger H, Kirste S, Rieken S, Petersen C, Nicolay NH, Fokas E, Dunst J, Rades D, Eble MJ, Krause M, Roedel C, Medenwald D, Niehoff P, Wittig-Sauerwein A, Baues C, Grosu A, Hoeppner J Neoadjuvant Chemoradiation (CROSS) vs. Perioperative Chemotherapy (FLOT) in Esophageal Adenocarcinoma (EAC): ESOPEC - a Randomised Controlled Prospective Multicentre Phase Ill Trial Int J Radiat Oncol Biol Phys 120 Suppl S(2):S6-S6. 2024.
DOI: nicht verfügbar
26. Deloch L, Weissmann T, Matschke J, Stefanowicz S, Grohmann M, Ehret F, Fabian A, Ruehle A, Wegen S, Lettmaier S, Trommer M, Sperk E, Schroeder A German Radiation Oncology's Next Generation: A web-based Survey of Young Biologists, Medical Physicists, and Physicians Oncology Research and Treatment 47 Suppl 1:220-221. 2024.
DOI: nicht verfügbar
27. Wegen S, Claus K, Linde P, Rosenbrock J, Zander T, Tuchscherer A, Schroeder W, Schloesser H, Eich ML, Fischer T, Schomaecker K, Drzezga A, Kobe C, Roth KS, Weindler J Impact of FAPI/dual tracer PET/CT imaging on management and target volume definition of esophageal cancer Oncology Research and Treatment 47 Suppl 1:14-14. 2024.
DOI: nicht verfügbar
28. Diefenhardt M, Martin D, Hofheinz RD, Ghadimi M, Fokas E, Rödel C, Fleischmann M Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal Cancer. JAMA Netw Open 7(9). 2024.
DOI: https://doi.org/10.1001/jamanetworkopen.2024.32927
29. Trommer M, Gaasch A, Corradini S [Pembrolizumab and radiochemotherapy in locally advanced cervical cancer-the prospective, randomised KEYNOTE-A18 phase 3 study]. Strahlenther Onkol 200(11):994-996. 2024.
DOI: https://doi.org/10.1007/s00066-024-02298-4
30. Trommer M Radiotherapy plus durvalumab in locally advanced NSCLC: the DOLPHIN study Strahlenther Onkol 200(7):646-648. 2024.
DOI: https://doi.org/10.1007/s00066-024-02231-9
31. Fleischmann M, Dapper H, Diefenhardt M, Martin D, Tselis N, Roedel C, Fokas E Percutaneous radiotherapy combined with endorectal brachytherapy for organ preservation in elderly/frail patients with rectal cancer, the ACO/ARO/AIO-22 trial Onkologie (Heidelberg, Germany) 30(2):129-132. 2024.
DOI: https://doi.org/10.1007/s00761-023-01470-2
32. Oji N [Staphylococcus aureus colonization as a risk factor for acute radiation dermatitis]. Strahlenther Onkol 200(6):549-552. 2024.
DOI: https://doi.org/10.1007/s00066-024-02227-5
33. Pollet N, Trommer M, Shabli S, Marnitz S, Sharma SJ [The COVID-pandemic and specialist training in Head and Neck oncology: A Survey among Physicians]. Laryngorhinootologie 103(6):432-442. 2024.
DOI: https://doi.org/10.1055/a-2259-9492
34. Buettner M, Melton P, Fietkau R, Petersen C, Krause M, Borgmann K, Wolf U, Niyazi M, Christiansen H, Hoeller U, Schmitt D, Linde P, Fleischmann DF, Ziegler S, Maeurer M, Kaesmann L Development and Future Prospects of Online Educational Lectures of the German Society for Radiation Oncology (DEGRO) Int J Radiat Oncol Biol Phys 119(4):E5-E5. 2024.
DOI: nicht verfügbar
35. Kobe C, Kaul H, Schneider G, Fuchs M, Eich H, Rosenbrock J, Baues C, Roth K, Drzezga A, van Heek L, Dietlein M, Borchmann P, Ferdinandus J Metabolic tumor volume after two cycles of chemotherapy in patients treated for advanced-stage Hodgkin Lymphoma: analysis of the German Hodgkin Study Group phase III HD18 and HD21 trials Eur J Nucl Med Mol Imaging 51 Suppl 1:S234-S234. 2024.
DOI: nicht verfügbar
36. Weindler J, Roth K, Fischer T, Schomaecker K, Bruns C, Ferdinandus S, Linde P, Rosenbrock J, Drzezga A, Kobe C Impact of [68Ga]-FAPI /[18F]FDG-dual tracer PET/CT imaging on radiotherapeutic management and target volume definition in esophageal cancer J Nucl Med 65 Suppl 2. 2024.
DOI: nicht verfügbar
37. Trommer M, Marnitz S, Koehler C, Tsunoda A, Baues C, Herter J, Wegen S, Morgenthaler J, Fokas E, Lapuz C, Khor R, Hagemeier A, Theurich S Body composition and inflammation affect outcome of cervical cancer patients under radiochemotherapy Radiother Oncol 194 Suppl 1:S1001-S1004. 2024.
DOI: nicht verfügbar
38. Trommer M, Gillett P, Trapani K, Hornby C, Herath D, Gough K, Donohoe K, Tran P, Ijzerman M, Franchini F, Khor R Travel distance patterns of palliative radiotherapy patients in Victoria, Australia Radiother Oncol 194 Suppl 1:S2784-S2786. 2024.
DOI: nicht verfügbar
39. Hofheinz RD, Herrle F, Dechow T, von Weikersthal LF, Welslau M, Lettmaier S, Burkart C, Kubicka S, Kochen L, Merx K, Krause K, Ebert M, Rödel C, Fokas E, Ghadimi M, Reissfelder C, Gaiser T mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214). ESMO Open 9(9). 2024.
DOI: https://doi.org/10.1016/j.esmoop.2024.103703
40. Trommer S, Mueller JA, Oertel M, Ehret F, Roohani S, Lange T, Maeurer M, Ha HM, Ngo Q, Dobiasch S, Domschikowski J, Gkika E, Hering K, Kuhnt T, Scafa D, Trommer M, Waltenberger M, Vordermark D, Medenwald D Change in Tumor Volume at Boost Planning to Predict Response to Chemoradiotherapy in inoperable stage III NSCLC ( TORCH study) Oncology Research and Treatment 47 Suppl 1:192-192. 2024.
DOI: nicht verfügbar
41. Wegen S, Nestle U, Zamboglou C, Spohn SKB, Nicolay NH, Fendler W, Holzgreve A, Werner R, Schmidt-Hegemann NS Implementation of PET/CT in radiation oncology - a patternsof-care analysis of the German Society of Nuclear Medicine (DGN) and the German Society of Radiation Oncology (DEGRO) Oncology Research and Treatment 47 Suppl 1:194-195. 2024.
DOI: nicht verfügbar
2023
34 Publikationen
1. Herter JM, Kiljan M, Kunze S, Reinscheid M, Ibruli O, Cai J, Niu L, Heßelmann I, Trommer M, Herter-Sprie GS, Köhler C, Marnitz S Influence of chemoradiation on the immune microenvironment of cervical cancer patients. Strahlenther Onkol 199(2):121-130. 2023.
DOI: https://doi.org/10.1007/s00066-022-02007-z
2. Linde P, Mallmann M, Adams A, Wegen S, Fan J, Rosenbrock J, Trommer M, Marnitz S, Baues C, Celik E The Role of Age and Comorbidities in Esophagogastric Cancer Chemoradiation of the Frail Elderly (>70 Years): An Analysis from a Tertiary High Volume-Center. Cancers (Basel) 15(1). 2023.
DOI: https://doi.org/10.3390/cancers15010106
3. Linde P, Klein M, Lang F, Wegen S, Petersen C, Dapper H, Fan J, Celik E, Marnitz S, Baues C Teaching in radiation oncology: now and 2025-results of a focus group with medical students. Strahlenther Onkol 199(4):360-369. 2023.
DOI: https://doi.org/10.1007/s00066-022-01997-0
4. Rosenbrock J, Lieser A, Ostermann-Myrau J, Judge M, Linde P, Claus K, Marnitz S, Kocher M, Baues C, Celik E Efficacy and Toxicity of Robotic Stereotactic Body Radiotherapy of Lung Metastases in Patients With Oligometastatic Disease. Anticancer Res 43(9):4125-4131. 2023.
DOI: https://doi.org/10.21873/anticanres.16602
5. Knöll P, Lenschow M, Lenz M, Neuschmelting V, von Spreckelsen N, Telentschak S, Olbrück S, Weber M, Rosenbrock J, Eysel P, Walter SG Local Recurrence and Development of Spinal Cord Syndrome during Follow-Up after Surgical Treatment of Metastatic Spine Disease. Cancers (Basel) 15(19). 2023.
DOI: https://doi.org/10.3390/cancers15194749
6. Roth K, Wegen S, Weindler J, Voltin C, van Heek L, Schomaecker K, Fischer T, Marnitz S, Kobe C, Drzezga A Dual-tracer PET/CT protocol with [18F]FDG and [68Ga] Ga-FAPI-46 outperforms single-tracer PET/CT with [18F] FDG in gastrointestinal and head and neck cancer, due to higher tumour to background ratio and larger gross and functional tumour volume. Eur J Nucl Med Mol Imaging 50 Suppl 1(SUPPL 1):S492-S492. 2023.
DOI: nicht verfügbar
7. Ruhle A, Roesch J, Oertel M, Fabian A, Wegen S, Trommer M, Hering D, Maeurer M, Dobiasch S, von der Gruen J, Medenwald D, Suess C, Hoeck M, Fleischmann DF, Loeser A, Hess S, Tamaskovic B, Vinsensia M, Hecht M, Nicolay NH MRI, FDG-PET/CT and Image-Guidance for Re-Irradiation of Locoregionally Recurrent or Second Primary Head-and-Neck Squamous Cell Carcinoma Patients Results of a Multicenter Cohort Study Int J Radiat Oncol Biol Phys 117 Suppl S(2):E619-E620. 2023.
DOI: nicht verfügbar
8. Wollring M, Lowis C, Stoffels G, Werner JM, Celik E, Baues C, Ruge M, Ruess D, Fink G, Langen KJ, Lohmann P, Galldiks N CHARACTERIZATION OF LONG-TERM METABOLIC CHANGES OF BRAIN METASTASES AFTER TREATMENT WITH STEREOTACTIC RADIOSURGERY USING SERIAL FET PET IMAGING Neuro-oncol 25 Suppl 5. 2023.
DOI: nicht verfügbar
9. Fleischmann DF, Buettner M, Oertel M, Waltenberger M, Suess C, Ziegler S, Kaesmann L, Jazmati D, Schroeder A, Maeurer M, Linde P Current situation in radiation oncology residency-Results of a national survey performed by the working group Young DEGRO of the German Society of Radiation Oncology. Strahlenther Onkol 199(11):961-972. 2023.
DOI: https://doi.org/10.1007/s00066-023-02137
10. Oertel M, Hering D, Kittel C, Nacke N, Kroeger K, Kriz J, Fuchs M, Baues C, Vordermark D, Engenhart-Cabillic R, Herfarth KK, Lukas P, Schmidberger H, Marnitz-Schulze S, Borchmann P, Engert A, Haverkamp U, Eich HTT Quality Analysis of Radiation Therapy for Hodgkin Lymphoma in the HD 16/17 Trials: A Final Report By the Reference Radiation Oncology Panel of the German Hodgkin Study Group Int J Radiat Oncol Biol Phys 117 Suppl S(2):S62-S62. 2023.
DOI: nicht verfügbar
11. Trommer M, Adams A, Bürkle C, Brunner S, Grandoch A, Geffroy A, Franklin C, Gassa A, Meißner AK, Mellinghoff S, Sharma SJ, Schrittenlocher S, Witte L, Marnitz S Impact of the COVID-19 pandemic on training conditions and education in oncologic disciplines: a survey-based analysis. Strahlenther Onkol 199(9):806-819. 2023.
DOI: https://doi.org/10.1007/s00066-023-02121-6
12. Celik E, Baues C, Trommer M, Fan J, Nadjiri L, Rosenbrock J, Linde P Dose-dependent Effects of Unintended Splenic Irradiation After Neoadjuvant Radiochemotherapy for Esophageal Cancer. Anticancer Res 43(6):2733-2739. 2023.
DOI: https://doi.org/10.21873/anticanres.16440
13. Fan J, Adams A, Sieg N, Heger JM, Gödel P, Kutsch N, Kaul D, Teichert M, von Tresckow B, Bücklein V, Goesmann G, Li M, Struve N, Trommer M, Linde P, Rosenbrock J, Celik E, Penack O, Stuschke M, Subklewe M, Belka C, von Bergwelt-Baildon M, Borchmann P, Marnitz S, Baues C Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy. Radiother Oncol 183. 2023.
DOI: https://doi.org/10.1016/j.radonc.2023.109580
14. Fabian A, Rühle A, Domschikowski J, Trommer M, Wegen S, Becker JN, Wurschi G, Boeke S, Sonnhoff M, Fink CA, Käsmann L, Schneider M, Bockelmann E, Treppner M, Mehnert-Theuerkauf A, Krug D, Nicolay NH, Young DEGRO Group Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany. J Cancer Res Clin Oncol 149(11):9017-9024. 2023.
DOI: https://doi.org/10.1007/s00432-023-04837-5
15. Fan J, Adams A, Sieg N, Heger J, Goedel P, Kutsch N, Kaul D, Teichert M, von Tresckow B, Buecklein V, Goesmann G, Li M, Struve N, Trommer M, Linde P, Rosenbrock J, Celik E, Penack O, Stuschke M, Belka C, von Bergwelt-Baildon M, Borchmann P, Marnitz S, Baues C A multicentric retrospective analysis of the potential synergy between radiotherapy and CAR T-cells Radiother Oncol 182 Suppl 1:S800-S801. 2023.
DOI: nicht verfügbar
16. Oertel M, Hering D, Nacke N, Kittel C, Kröger K, Kriz J, Fuchs M, Baues C, Vordermark D, Engenhart-Cabillic R, Herfarth K, Lukas P, Schmidberger H, Marnitz S, Borchmann P, Engert A, Haverkamp U, Eich HT Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era. Adv Radiat Oncol 8(3). 2023.
DOI: https://doi.org/10.1016/j.adro.2022.101169
17. Rueß D, Schütz B, Celik E, Baues C, Jünger ST, Neuschmelting V, Hellerbach A, Eichner M, Kocher M, Ruge MI Pseudoprogression of Vestibular Schwannoma after Stereotactic Radiosurgery with Cyberknife®: Proposal for New Response Criteria. Cancers (Basel) 15(5). 2023.
DOI: https://doi.org/10.3390/cancers15051496
18. Knoth J, Konrad S, Lössl K, Motisi L, Mäurer M, Linde P, Lindel K, Niehoff P, Strnad V, Sturdza A, Corradini S Survey on brachytherapy training among radiation oncology residents in the German-speaking regions of Europe. Strahlenther Onkol 199(9):798-805. 2023.
DOI: https://doi.org/10.1007/s00066-023-02108-3
19. Rosenbrock J, Baues C, Kreis M, Fouassi R, Celik E, Paffenholz P, Pfister D, Heidenreich A, Marnitz S Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer. Strahlenther Onkol 199(6):574-584. 2023.
DOI: https://doi.org/10.1007/s00066-023-02060-2
20. Fabian A, Rühle A, Domschikowski J, Trommer M, Wegen S, Becker JN, Wurschi G, Boeke S, Sonnhoff M, Fink CA, Käsmann L, Schneider M, Bockelmann E, Treppner M, Krug D, Nicolay NH, Young DEGRO Group Financial toxicity in cancer patients undergoing radiotherapy in a universal health care system - A prospective multicenter study of 1075 patients. Radiother Oncol 183. 2023.
DOI: https://doi.org/10.1016/j.radonc.2023.109604
21. Roesch J, Oertel M, Wegen S, Trommer M, Schleifenbaum J, Hering D, Mäurer M, Knippen S, Dobiasch S, Waltenberger M, von der Grün J, Medenwald D, Süß C, Hoeck M, Käsmann L, Fleischmann DF, Rühle A, Nicolay NH, Fabian A, Löser A, Heß S, Tamaskovics B, Vinsensia M, Hecht M, Young DEGRO Group Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis. Radiother Oncol 181. 2023.
DOI: https://doi.org/10.1016/j.radonc.2022.10.007
22. von Spreckelsen N, Ossmann J, Lenz M, Nadjiri L, Lenschow M, Telentschak S, Meyer J, Keßling J, Knöll P, Eysel P, Goldbrunner R, Perrech M, Scheyerer M, Celik E, Zarghooni K, Neuschmelting V Role of Decompressive Surgery in Neurologically Intact Patients with Low to Intermediate Intraspinal Metastatic Tumor Burden. Cancers (Basel) 15(2). 2023.
DOI: https://doi.org/10.3390/cancers15020385
23. Wegen S, Roth KS, Weindler J, Claus K, Linde P, Trommer M, Akuamoa-Boateng D, van Heek L, Baues C, Schömig-Markiefka B, Schomäcker K, Fischer T, Drzezga A, Kobe C, Köhler C, Marnitz S First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer. Clin Nucl Med 48(2):150-155. 2023.
DOI: https://doi.org/10.1097/RLU.0000000000004505
24. Fabian A, Ruehle A, Trommer M, Wegen S, Becker J, Wurschi G, Boeke S, Sonnhoff M, Fink CA, Kaesmann L, Schneider M, Bockelmann E, Treppner M, Krug D, Nicolay NH Financial toxicity in cancer patients treated with radiotherapy - a yDEGRO cross-sectional study Radiother Oncol 182 Suppl 1:S41-S41. 2023.
DOI: nicht verfügbar
25. Buettner M, Melton P, Fietkau R, Petersen C, Krause M, Borgmann K, Wolf U, Niyazi KM, Hoeller U, Schmitt D, Kaesmann L, Linde P, Fleischmann D, Ziegler S, Bresch A, Maeurer M Successful Establishment of the DEGRO/jDEGRO Webinar Strahlenther Onkol 199 Suppl 1:S25-S25. 2023.
DOI: nicht verfügbar
26. Fleischmann D, Buettner M, Oertel M, Waltenberger M, Suess C, Ziegler S, Kaesmann L, Jazmati D, Schroeder A, Maeurer M, Linde P Current Situation of Further Training for Doctors in Radiation Oncology - a Survey by the Further Training Section of the Young DEGRO Group Strahlenther Onkol 199 Suppl 1:S159-S160. 2023.
DOI: nicht verfügbar
27. Oertel M, Storck M, Goerlich D, Schnellhardt S, Bock F, Linde P, Domschikowski J, Peeken J, Wittig A, Elsayad K, Siats J, Rolf D, Combs SE, Baues C, Dunst J, Hildebrandt G, Fietkau R, Eich HT Radiotherapeutic Treatment of indolent cutaneous B-cell Lymphomas - Results of a multicenter Registry Strahlenther Onkol 199 Suppl 1:S53-S54. 2023.
DOI: nicht verfügbar
28. Oertel M, Linde P, Hartong N, Maeurer M, Vorwerk H, Schmidberger H, Combs SE, Dapper H Development of a modern radiation oncology Curriculum within the National Competence and Learning Goals Catalog of Medicine - Results and Experiences of the DEGRO Teaching Working Group Strahlenther Onkol 199 Suppl 1:S158-S158. 2023.
DOI: nicht verfügbar
29. Ruehle A, Fabian A, Domschikowski J, Trommer M, Wegen S, Becker JN, Wurschi G, Boeke S, Sonnhoff M, Fink C, Kaesmann L, Schneider M, Bockelmann E, Treppner M, Krug D, Nicolay NH Psychosocial Stress after Radiation Therapy - secondary Analysis of a prospective multicenter Study with 1075 Patients Strahlenther Onkol 199 Suppl 1:S30-S30. 2023.
DOI: nicht verfügbar
30. Linde P, Krug D, Fleischmann D, Ziegler S, Kaesmann L, Jazmati D, Schroeder A, Waltenberger M, Maeurer M The Internship Programs of the Young DEGRO Group - Development of a European Training and Support Platform as well as Initial Reports of Experiences Strahlenther Onkol 199 Suppl 1:S160-S160. 2023.
DOI: nicht verfügbar
31. Mayer M, Hofmaier J, Neppl S, Walter F, Niyazi K, Marnitz-Schulze S, Baues C, Kamp F variance-based sensitivity analysis (SA) for the evaluation of margin concepts in radiotherapy Radiother Oncol 182 Suppl 1:S514-S515. 2023.
DOI: nicht verfügbar
32. Trommer S, Mueller JA, Dobiasch S, Domschikowski J, Ehret F, Gkika E, Ha HM, Hering K, Kuhnt T, Lange T, Maurer M, Oertel M, Roohani S, Scafa D, Trommer M, Waltenberger M, Vordermark D, Medenwald D Tumor Volume Change in CT Diagnostics for Boost Radiation Planning to Assess Response to Chemoradiotherapy in Inoperable Stage III NSCLC (TORCH Study) Strahlenther Onkol 199 Suppl 1:S100-S100. 2023.
DOI: nicht verfügbar
33. Rehn S, Oertel M, Linde P, Maeurer M, Pepper NB, Rolf D, Elsayad K, Eich HT Status quo of continuing education in radiation therapy in the field of haemato-oncology - results of a national survey Strahlenther Onkol 199 Suppl 1:S109-S109. 2023.
DOI: nicht verfügbar
34. Diefenhardt M, Fleischmann M, Martin D, Hofheinz RD, Piso P, Germer CT, Hambsch P, Grützmann R, Kirste S, Schlenska-Lange A, Ghadimi M, Rödel C, Fokas E, German Rectal Cancer Study Group Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials. Radiother Oncol 179. 2023.
DOI: https://doi.org/10.1016/j.radonc.2022.109455
2022
20 Publikationen
1. Rosenbrock J, Baues C, Vasquez-Torres A, Clivio A, Fogliata A, Borchmann P, Marnitz S, Cozzi L Volumetric modulated arc therapy versus intensity-modulated proton therapy in the irradiation of infra diaphragmatic Hodgkin Lymphoma in female patients. Acta Oncol 61(1):81-88. 2022.
DOI: https://doi.org/10.1080/0284186X.2021.1986230
2. Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC, Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN Correction to: Value of PET imaging for radiation therapy. Strahlenther Onkol 198(1):80-82. 2022.
DOI: https://doi.org/10.1007/s00066-021-01851-9
3. Hellerbach A, Eichner M, Rueß D, Luyken K, Hoevels M, Judge M, Baues C, Ruge M, Kocher M, Treuer H Impact of prescription isodose level and collimator selection on dose homogeneity and plan quality in robotic radiosurgery. Strahlenther Onkol 198(5):484-496. 2022.
DOI: https://doi.org/10.1007/s00066-021-01872-4
4. Dietzsch S, Braesigk A, Seidel C, Remmele J, Kitzing R, Schlender T, Mynarek M, Geismar D, Jablonska K, Schwarz R, Pazos M, Weber DC, Frick S, Gurtner K, Matuschek C, Harrabi SB, Glück A, Lewitzki V, Dieckmann K, Benesch M, Gerber NU, Obrecht D, Rutkowski S, Timmermann B, Kortmann RD Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial. Strahlenther Onkol 198(3):282-290. 2022.
DOI: https://doi.org/10.1007/s00066-021-01822-0
5. Linde P, Mallmann M, Adams A, Wegen S, Rosenbrock J, Trommer M, Marnitz S, Baues C, Celik E Chemoradiation for elderly patients (≥ 65 years) with esophageal cancer: a retrospective single-center analysis. Radiat Oncol 17(1). 2022.
DOI: https://doi.org/10.1186/s13014-022-02160-w
6. Trommer M, Adams A, Celik E, Fan J, Funken D, Herter JM, Linde P, Morgenthaler J, Wegen S, Mauch C, Franklin C, Galldiks N, Werner JM, Kocher M, Rueß D, Ruge M, Meißner AK, Baues C, Marnitz S Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups. Cancers (Basel) 14(5). 2022.
DOI: https://doi.org/10.3390/cancers14051240
7. Franklin C, Mohr P, Bluhm L, Grimmelmann I, Gutzmer R, Meier F, Garzarolli M, Weichenthal M, Pfoehler C, Herbst R, Terheyden P, Utikal J, Ulrich J, Debus D, Haferkamp S, Kaatz M, Forschner A, Leiter U, Nashan D, Kreuter A, Sachse M, Welzel J, Heinzerling L, Meiss F, Weishaupt C, Gambichler T, Weyandt G, Dippel E, Schatton K, Celik E, Trommer M, Helfrich I, Roesch A, Zimmer L, Livingstone E, Schadendorf D, Horn S, Ugurel S Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. J Immunother Cancer 10(6). 2022.
DOI: https://doi.org/10.1136/jitc-2022-004509
8. Simões Corrêa Galendi J, Yeo SY, Grüll H, Bratke G, Akuamoa-Boateng D, Baues C, Bos C, Verkooijen HM, Shukri A, Stock S, Müller D Early economic modeling of magnetic resonance image-guided high intensity focused ultrasound compared to radiotherapy for pain palliation of bone metastases. Front Oncol 12. 2022.
DOI: https://doi.org/10.3389/fonc.2022.987546
9. Wegen S, van Heek L, Linde P, Claus K, Akuamoa-Boateng D, Baues C, Sharma SJ, Schomäcker K, Fischer T, Roth KS, Klußmann JP, Marnitz S, Drzezga A, Kobe C Head-to-Head Comparison of [68 Ga]Ga-FAPI-46-PET/CT and [18F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer. Mol Imaging Biol 24(6):986-994. 2022.
DOI: https://doi.org/10.1007/s11307-022-01749-7
10. Kohler C, Kettner P, Arnold D, Puhl G, Marnitz S, Plaikner A Repeated intravenous indocyanine green application to prove uterine perfusion during uterus transposition. Int J Gynecol Cancer 32(11):1479-1480. 2022.
DOI: https://doi.org/10.1136/ijgc-2022-003647
11. Lenschow M, Lenz M, von Spreckelsen N, Ossmann J, Meyer J, Keßling J, Nadjiri L, Telentschak S, Zarghooni K, Knöll P, Perrech M, Celik E, Scheyerer M, Neuschmelting V Impact of Spinal Instrumentation on Neurological Outcome in Patients with Intermediate Spinal Instability Neoplastic Score (SINS). Cancers (Basel) 14(9). 2022.
DOI: https://doi.org/10.3390/cancers14092193
12. Marnitz S, Bereuter AS [Radiotherapy versus inguinofemoral lymphadenectomy in vulvar cancer patients with micrometastases in the sentinel node]. Strahlenther Onkol 198(6):595-597. 2022.
DOI: https://doi.org/10.1007/s00066-022-01922-5
13. Baues C, Marnitz S, Lukas P, Herfarth K, Engenhart-Cabillic R, Schmidberger H, Eich H Role of radiotherapy in Hodgkin lymphoma Onkologie (Heidelberg, Germany) 28(10):872-878. 2022.
DOI: https://doi.org/10.1007/s00761-022-01185-w
14. Sasse S, Momotow J, Broeckelmann PJ, Baues C, Eich HT, Engert A Treatment of early stage favorable and unfavorable Hodgkin lymphoma Onkologie (Heidelberg, Germany) 28(10):879-888. 2022.
DOI: https://doi.org/10.1007/s00761-022-01228-2
15. Kluge A, Ehrbar S, Grehn M, Fleckenstein J, Baus WW, Siebert FA, Schweikard A, Andratschke N, Mayinger MC, Boda-Heggemann J, Buergy D, Celik E, Krug D, Kovacs B, Saguner AM, Rudic B, Bergengruen P, Boldt LH, Stauber A, Zaman A, Bonnemeier H, Dunst J, Budach V, Blanck O, Mehrhof F Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial. Int J Radiat Oncol Biol Phys 114(2):360-372. 2022.
DOI: https://doi.org/10.1016/j.ijrobp.2022.06.056
16. van Heek L, Stuka C, Kaul H, Müller H, Mettler J, Hitz F, Baues C, Fuchs M, Borchmann P, Engert A, Dietlein M, Voltin CA, Kobe C Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial. BMC Cancer 22(1). 2022.
DOI: https://doi.org/10.1186/s12885-022-09758-z
17. Kobe C, Baues C, Borchmann S, Fuchs M, Borchmann P, Eich HT, Dietlein M FDG-positron emission tomography/computed tomography and new opportunities for risk stratification Onkologie (Heidelberg, Germany) 28(10):853-861. 2022.
DOI: https://doi.org/10.1007/s00761-022-01187-8
18. Beckmann MW, Stübs FA, Koch MC, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L, Hack CC, Ehret A, Gantert D, Martignoni F, Cieslik JP, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, Grimm C, Sturdza A, Wight E, Loessl K, Golatta M, Hagen V, Dauelsberg T, Diel I, Münstedt K, Merz E, Vordermark D, Lindel K, Wittekind C, Küppers V, Lellé R, Neis K, Griesser H, Pöschel B, Steiner M, Freitag U, Gilster T, Schmittel A, Friedrich M, Haase H, Gebhardt M, Kiesel L, Reinhardt M, Kreißl M, Kloke M, Horn LC, Wiedemann R, Marnitz S, Letsch A, Zraik I, Mangold B, Möckel J, Alt C, Wimberger P, Hillemanns P, Paradies K, Mustea A, Denschlag D, Henscher U, Tholen R, Wesselmann S, Fehm T Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy. Geburtsh Frauenheilk 82(2):139-180. 2022.
DOI: https://doi.org/10.1055/a-1671-2158
19. Fehm T, Stübs FA, Koch MC, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L, Carolin C.Hack , Ehret A, Gantert D, Martignoni F, Cieslik JP, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, Grimm C, Sturdza A, Wight E, Loessl K, Golatta M, Hagen V, Dauelsberg T, Diel I, Münstedt K, Merz E, Vordermark D, Lindel K, Wittekind C, Küppers V, Lellé R, Neis K, Griesser H, Pöschel B, Steiner M, Freitag U, Gilster T, Schmittel A, Friedrich M, Haase H, Gebhardt M, Kiesel L, Reinhardt M, Kreißl M, Kloke M, Horn LC, Wiedemann R, Marnitz S, Letsch A, Zraik I, Mangold B, Möckel J, Alt C, Wimberger P, Hillemanns P, Paradies K, Mustea A, Denschlag D, Henscher U, Tholen R, Wesselmann S, Beckmann MW Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities. Geburtsh Frauenheilk 82(2):181-205. 2022.
DOI: https://doi.org/10.1055/a-1671-2446
20. Roth KS, Voltin CA, van Heek L, Wegen S, Schomäcker K, Fischer T, Marnitz S, Drzezga A, Kobe C Dual-Tracer PET/CT Protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept. J Nucl Med 63(11):1683-1686. 2022.
DOI: https://doi.org/10.2967/jnumed.122.263835
2021
38 Publikationen
1. Morgenthaler J, Köhler C, Budach V, Sehouli J, Stromberger C, Besserer A, Trommer M, Baues C, Marnitz S Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer. Strahlenther Onkol 197(6):474-486. 2021.
DOI: https://doi.org/10.1007/s00066-020-01685-x
2. Akuamoa-Boateng D, Wegen S, Ferdinandus J, Marksteder R, Baues C, Marnitz S Correction to: Managing patient flows in radiation oncology during the COVID-19 pandemic : Reworking existing treatment designs to prevent infections at a German hot spot area University Hospital. Strahlenther Onkol 197(2):158-158. 2021.
DOI: https://doi.org/10.1007/s00066-020-01724-7
3. Celik E, Baues C, Claus K, Fogliata A, Scorsetti M, Marnitz S, Cozzi L Knowledge-based intensity-modulated proton planning for gastroesophageal carcinoma. Acta Oncol 60(3):285-292. 2021.
DOI: https://doi.org/10.1080/0284186X.2020.1845396
4. Dietzsch S, Braesigk A, Seidel C, Remmele J, Kitzing R, Schlender T, Mynarek M, Geismar D, Jablonska K, Schwarz R, Pazos M, Walser M, Frick S, Gurtner K, Matuschek C, Harrabi SB, Glück A, Lewitzki V, Dieckmann K, Benesch M, Gerber NU, Rutkowski S, Timmermann B, Kortmann RD Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial. Strahlenther Onkol 197(8):674-682. 2021.
DOI: https://doi.org/10.1007/s00066-020-01707-8
5. Borchmann P, Plütschow A, Kobe C, Greil R, Meissner J, Topp MS, Ostermann H, Dierlamm J, Mohm J, Thiemer J, Sökler M, Kerkhoff A, Ahlborn M, Halbsguth TV, Martin S, Keller U, Balabanov S, Pabst T, Vogelhuber M, Hüttmann A, Wilhelm M, Zijlstra JM, Moccia A, Kuhnert G, Bröckelmann PJ, von Tresckow B, Fuchs M, Klimm B, Rosenwald A, Eich H, Baues C, Marnitz S, Hallek M, Diehl V, Dietlein M, Engert A PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 22(2):223-234. 2021.
DOI: https://doi.org/10.1016/S1470-2045(20)30601-X
6. Bröckelmann PJ, Müller H, Guhl T, Behringer K, Fuchs M, Moccia AA, Rank A, Soekler M, Vieler T, Pabst T, Baues C, von Tresckow B, Borchmann P, Engert A Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. J Clin Oncol 39(2):107-115. 2021.
DOI: https://doi.org/10.1200/JCO.20.00947
7. Eichenauer DA, Kreissl S, Bühnen I, Baues C, Kobe C, van Heek L, Goergen H, Fuchs M, Hartmann S, von Tresckow B, Engert A, Borchmann P PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study. Ann Oncol 32(6):807-810. 2021.
DOI: https://doi.org/10.1016/j.annonc.2021.02.018
8. Kiljan M, Weil S, Vásquez-Torres A, Hettich M, Mayer M, Ibruli O, Reinscheid M, Heßelmann I, Cai J, Niu LN, Sahbaz Y, Baues C, Baus WW, Kamp F, Marnitz S, Herter-Sprie GS, Herter JM CyberKnife radiation therapy as a platform for translational mouse studies. Int J Radiat Biol 97(9):1261-1269. 2021.
DOI: https://doi.org/10.1080/09553002.2021.1934749
9. Werner JM, Weller J, Ceccon G, Schaub C, Tscherpel C, Lohmann P, Bauer EK, Schäfer N, Stoffels G, Baues C, Celik E, Marnitz S, Kabbasch C, Gielen GH, Fink GR, Langen KJ, Herrlinger U, Galldiks N Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET. Clin Cancer Res 27(13):3704-3713. 2021.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-0471
10. Marnitz S, Schömig-Markiefka B [The PORTEC-3 trial for high-risk endometrial cancer: impact of molecular classification on prognosis and benefit from adjuvant therapy]. Strahlenther Onkol 197(3):266-268. 2021.
DOI: https://doi.org/10.1007/s00066-020-01735-4
11. Boda-Heggemann J, Blanck O, Mehrhof F, Ernst F, Buergy D, Fleckenstein J, Tülümen E, Krug D, Siebert FA, Zaman A, Kluge AK, Parwani AS, Andratschke N, Mayinger MC, Ehrbar S, Saguner AM, Celik E, Baus WW, Stauber A, Vogel L, Schweikard A, Budach V, Dunst J, Boldt LH, Bonnemeier H, Rudic B Interdisciplinary Clinical Target Volume Generation for Cardiac Radioablation: Multicenter Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial. Int J Radiat Oncol Biol Phys 110(3):745-756. 2021.
DOI: https://doi.org/10.1016/j.ijrobp.2021.01.028
12. Voltin CA, Mettler J, van Heek L, Goergen H, Müller H, Baues C, Keller U, Meissner J, Trautmann-Grill K, Kerkhoff A, Fuchs M, Sasse S, von Tresckow B, Dietlein M, Borchmann P, Engert A, Kobe C, Bröckelmann PJ Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial. Clin Cancer Res 27(2):402-407. 2021.
DOI: https://doi.org/10.1158/1078-0432.CCR-20-3303
13. Hofmaier J, Walter F, Hadi I, Rottler M, von Bestenbostel R, Dedes G, Parodi K, Niyazi M, Belka C, Kamp F Combining inter-observer variability, range and setup uncertainty in a variance-based sensitivity analysis for proton therapy. Phys Imaging Radiat Oncol 20:117-120. 2021.
DOI: https://doi.org/10.1016/j.phro.2021.11.005
14. Krug D, Hecht M, Ebert N, Mäurer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, Hörner-Rieber J, Schmitt D, von Neubeck C, Zamboglou C, Sperk E, Kaul D, Hess J, Corradini S, Seidel C, Gani C, Baues C, Frey B, Blanck O, Gauer T, Niyazi M Correction to: Innovative radiation oncology Together-Precise, Personalized, Human. Strahlenther Onkol 197(12):1049-1050. 2021.
DOI: https://doi.org/10.1007/s00066-021-01869-z
15. Krug D, Hecht M, Ebert N, Mäurer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, Hörner-Rieber J, Schmitt D, von Neubeck C, Zamboglou C, Sperk E, Kaul D, Heß-Rieger J, Corradini S, Seidel C, Gani C, Baues C, Frey B, Blanck O, Gauer T, Niyazi M Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany. Strahlenther Onkol 197(12):1043-1048. 2021.
DOI: https://doi.org/10.1007/s00066-021-01843-9
16. Ostheimer C, Mäurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, Giordano FA, Sautter L, López G, Fleischmann DF, Niyazi M, Käsmann L, Kaul D, Thieme AH, Billiet C, Dobiasch S, Arnold CR, Oertel M, Haussmann J, Gauer T, Goy Y, Suess C, Ziegler S, Panje CM, Baues C, Trommer M, Skripcak T, Medenwald D Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group. Strahlenther Onkol 197(6):560-561. 2021.
DOI: https://doi.org/10.1007/s00066-021-01750-z
17. Ostheimer C, Mäurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, Giordano FA, Sautter L, López G, Fleischmann DF, Niyazi M, Käsmann L, Kaul D, Thieme AH, Billiet C, Dobiasch S, Arnold CR, Oertel M, Haussmann J, Gauer T, Goy Y, Suess C, Ziegler S, Panje CM, Baues C, Trommer-Nestler M, Skripcak T, Medenwald D Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group. Strahlenther Onkol 197(5):385-395. 2021.
DOI: https://doi.org/10.1007/s00066-020-01727-4
18. Ruge MI, Tutunji J, Rueß D, Celik E, Baues C, Treuer H, Kocher M, Grau S Stereotactic radiosurgery for treating meningiomas eligible for complete resection. Radiat Oncol 16(1). 2021.
DOI: https://doi.org/10.1186/s13014-021-01748-y
19. Da Silva Mendes V, Nierer L, Li M, Corradini S, Reiner M, Kamp F, Niyazi M, Kurz C, Landry G, Belka C Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer. Radiat Oncol 16(1). 2021.
DOI: https://doi.org/10.1186/s13014-021-01858-7
20. Rosenbrock J, Vásquez-Torres A, Mueller H, Behringer K, Zerth M, Celik E, Fan J, Trommer M, Linde P, Fuchs M, Borchmann P, Engert A, Marnitz S, Baues C Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-Patients. Front Oncol 11. 2021.
DOI: https://doi.org/10.3389/fonc.2021.658358
21. Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC, “Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN” Value of PET imaging for radiation therapy. Nuklearmedizin 60(5):326-343. 2021.
DOI: https://doi.org/10.1055/a-1525-7029
22. Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC, Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN Value of PET imaging for radiation therapy. Strahlenther Onkol 197(9):1-23. 2021.
DOI: https://doi.org/10.1007/s00066-021-01812-2
23. Telentschak S, Ruess D, Grau S, Goldbrunner R, von Spreckelsen N, Jablonska K, Treuer H, Kocher M, Ruge M Cyberknife® hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases. J Cancer Res Clin Oncol 147(9):2765-2773. 2021.
DOI: https://doi.org/10.1007/s00432-021-03564-z
24. Concin N, Creutzberg CL, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann JA, Bosse T, Chargari C, Fagotti A, Fotopoulou C, González-Martín A, Lax SF, Lorusso D, Marth C, Morice P, Nout RA, O'Donnell DE, Querleu D, Raspollini MR, Sehouli J, Sturdza AE, Taylor A, Westermann AM, Wimberger P, Colombo N, Planchamp F, Matias-Guiu X ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma. Virchows Arch 478(2):153-190. 2021.
DOI: https://doi.org/10.1007/s00428-020-03007-z
25. Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Gonzalez Martin A, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O'Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, Creutzberg CL ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 31(1):12-39. 2021.
DOI: https://doi.org/10.1136/ijgc-2020-002230
26. Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Martin AG, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O'Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, Creutzberg CL ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Radiother Oncol 154:327-353. 2021.
DOI: https://doi.org/10.1016/j.radonc.2020.11.018
27. Linde P, Baues C, Wegen S, Trommer M, Quaas A, Rosenbrock J, Celik E, Marnitz S, Bruns CJ, Fischer T, Schomaecker K, Wester HJ, Drzezga A, van Heek L, Kobe C Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach. Cancer Imaging 21(1). 2021.
DOI: https://doi.org/10.1186/s40644-021-00391-w
28. Chiapponi C, Alakus H, Faust M, Schultheis AM, Rosenbrock J, Schmidt M Salvage surgery for cervical radioiodine refractory 18F-FDG-PET positive recurrence of papillary thyroid cancer. Endocr Connect 10(9):1180-1188. 2021.
DOI: https://doi.org/10.1530/EC-21-0232
29. Fervers P, Celik E, Bratke G, Maintz D, Baues C, Ruffing S, Pollman-Schweckhorst P, Kottlors J, Lennartz S, Große Hokamp N Radiotherapy Response Assessment of Multiple Myeloma: A Dual-Energy CT Approach With Virtual Non-Calcium Images. Front Oncol 11. 2021.
DOI: https://doi.org/10.3389/fonc.2021.734819
30. Kreissl S, Goergen H, Buehnen I, Kobe C, Moccia A, Greil R, Eichenauer DA, Zijlstra JM, Markova J, Meissner J, Feuring-Buske M, Soekler M, Beck HJ, Willenbacher W, Ludwig WD, Pabst T, Topp MS, Hitz F, Bentz M, Keller UB, Kühnhardt D, Ostermann H, Hertenstein B, Aulitzky W, Maschmeyer G, Vieler T, Eich H, Baues C, Stein H, Fuchs M, Diehl V, Dietlein M, Engert A, Borchmann P, German Hodgkin Study Group PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial. Lancet Haematol 8(6):e398-e409. 2021.
DOI: https://doi.org/10.1016/S2352-3026(21)00101-0
31. Baues C, Goergen H, Fuchs M, Rosenbrock J, Celik E, Eich H, Kobe C, Voltin CA, Engert A, Borchmann P, Marnitz S Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial. Int J Radiat Oncol Biol Phys 111(4):900-906. 2021.
DOI: https://doi.org/10.1016/j.ijrobp.2021.07.1697
32. Grau S, Herling M, Mauch C, Galldiks N, Golla H, Schlamann M, Scheel AH, Celik E, Ruge M, Goldbrunner R [Brain metastases-Interdisciplinary approach towards a personalized treatment]. Chirurg 92(3):200-209. 2021.
DOI: https://doi.org/10.1007/s00104-020-01344-y
33. Galldiks N, Abdulla DS, Scheffler M, Wolpert F, Werner JM, Huellner MW, Stoffels G, Schweinsberg V, Schlaak M, Kreuzberg N, Landsberg J, Lohmann P, Ceccon G, Baues C, Trommer M, Celik E, Ruge MI, Kocher M, Marnitz S, Fink GR, Tonn JC, Weller M, Langen KJ, Wolf J, Mauch C Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences. J Nucl Med 62(4):464-470. 2021.
DOI: https://doi.org/10.2967/jnumed.120.248278
34. Hesselmann I, Reinscheid M, Kiljan M, Niu LN, Cai JL, Wagner E, Ibruli O, Sahbaz Y, Mayer M, Kamp F, Baues C, Marnitz S Synergy of HSP90 Inhibition and Radiation Therapy for cGAS/STING Pathway Activation FASEB J 35 Suppl 1. 2021.
DOI: https://doi.org/10.1096/fasebj.2021.35.S1.03404
35. Wagner E, Niu LN, Kiljan M, Ibruli O, Hesselmann I, Sahbaz Y, Cai JL, Hettich M, Mayer M, Kamp F, Baues C, Marnitz S, Herter JM, Herter-Sprie G Impact of radiation therapy on vascular endothelial adhesion receptor expression FASEB J 35 Suppl 1. 2021.
DOI: https://doi.org/10.1096/fasebj.2021.35.S1.03429
36. Cibula D, Borčinová M, Marnitz S, Jarkovský J, Klát J, Pilka R, Torné A, Zapardiel I, Petiz A, Lay L, Sehnal B, Ponce J, Felsinger M, Arencibia-Sánchez O, Kaščák P, Zalewski K, Presl J, Palop-Moscardó A, Tingulstad S, Vergote I, Redecha M, Frühauf F, Köhler C, Kocián R Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients. Cancers (Basel) 13(10). 2021.
DOI: https://doi.org/10.3390/cancers13102360
37. Schmitz HP, Rabe M, Janssens G, Bondesson D, Rit S, Parodi K, Belka C, Dinkel J, Kurz C, Kamp F, Landry G Validation of proton dose calculation on scatter corrected 4D cone beam computed tomography using a porcine lung phantom. Phys Med Biol 66(17). 2021.
DOI: https://doi.org/10.1088/1361-6560/ac16e9
38. Marnitz S [Importance of pre-operative immunohistochemistry in patients with endometrial cancer-which parameters do we need?] Strahlenther Onkol 197(12):1148-1150. 2021.